Literature DB >> 22238311

Functional interferon system is required for clearance of lassa virus.

Nadezhda E Yun1, Allison L Poussard, Alexey V Seregin, Aida G Walker, Jennifer K Smith, Judith F Aronson, Jeanon N Smith, Lynn Soong, Slobodan Paessler.   

Abstract

Lassa virus (LASV) is the causative agent of Lassa hemorrhagic fever (LF) in humans, a deadly disease endemic to West Africa that results in 5,000 to 10,000 deaths annually. Here we present results demonstrating that functional type I and type II interferon (IFN) signaling is required for efficient control of LASV dissemination and clearance.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22238311      PMCID： PMC3302329          DOI： 10.1128/JVI.06284-11

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  13 in total

1.  Experimental studies of arenaviral hemorrhagic fevers.

Authors:  C J Peters; P B Jahrling; C T Liu; R H Kenyon; K T McKee; J G Barrera Oro
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

2.  Clinical virology of Lassa fever in hospitalized patients.

Authors:  K M Johnson; J B McCormick; P A Webb; E S Smith; L H Elliott; I J King
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

3.  Pathologic and virologic study of fatal Lassa fever in man.

Authors:  D H Walker; J B McCormick; K M Johnson; P A Webb; G Komba-Kono; L H Elliott; J J Gardner
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

4.  Effective vaccine for lassa fever.

Authors:  S P Fisher-Hoch; L Hutwagner; B Brown; J B McCormick
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  T cell-dependence of Lassa fever pathogenesis.

Authors:  Lukas Flatz; Toni Rieger; Doron Merkler; Andreas Bergthaler; Tommy Regen; Mariann Schedensack; Lukas Bestmann; Admar Verschoor; Mario Kreutzfeldt; Wolfgang Brück; Uwe-Karsten Hanisch; Stephan Günther; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

6.  Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.

Authors:  P B Jahrling
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

7.  Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs.

Authors:  Nadezhda E Yun; Nathaniel S Linde; Natallia Dziuba; Michele A Zacks; Jeanon N Smith; Jennifer K Smith; Judy F Aronson; Olga V Chumakova; Heather M Lander; Clarence J Peters; Slobodan Paessler
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

8.  Pathogenesis of Lassa virus infection in guinea pigs.

Authors:  P B Jahrling; S Smith; R A Hesse; J B Rhoderick
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection.

Authors:  Ethan A Mack; Lara E Kallal; Delia A Demers; Christine A Biron
Journal:  MBio       Date:  2011-08-09       Impact factor: 7.867

10.  Development of a new vaccine for the prevention of Lassa fever.

Authors:  Thomas W Geisbert; Steven Jones; Elizabeth A Fritz; Amy C Shurtleff; Joan B Geisbert; Ryan Liebscher; Allen Grolla; Ute Ströher; Lisa Fernando; Kathleen M Daddario; Mary C Guttieri; Bianca R Mothé; Tom Larsen; Lisa E Hensley; Peter B Jahrling; Heinz Feldmann
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069
View more
  31 in total

1.  Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Authors:  Tatyana Yun; Arnold Park; Terence E Hill; Olivier Pernet; Shannon M Beaty; Terry L Juelich; Jennifer K Smith; Lihong Zhang; Yao E Wang; Frederic Vigant; Junling Gao; Ping Wu; Benhur Lee; Alexander N Freiberg
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Authors:  Melissa W Hayes; Ricardo Carrion; Jerritt Nunneley; Andrei E Medvedev; Maria S Salvato; Igor S Lukashevich
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 3.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

4.  Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection.

Authors:  Nadezhda E Yun; Shannon Ronca; Atsushi Tamura; Takaaki Koma; Alexey V Seregin; Kelly T Dineley; Milagros Miller; Rebecca Cook; Naoki Shimizu; Aida G Walker; Jeanon N Smith; Joseph N Fair; Nadia Wauquier; Bayon Bockarie; Sheik Humarr Khan; Tomoko Makishima; Slobodan Paessler
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

5.  Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain.

Authors:  Junji Xing; Zheng Chai; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

6.  Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Authors:  Nadezhda E Yun; Alexey V Seregin; David H Walker; Vsevolod L Popov; Aida G Walker; Jeanon N Smith; Milagros Miller; Juan C de la Torre; Jennifer K Smith; Viktoriya Borisevich; Joseph N Fair; Nadia Wauquier; Donald S Grant; Bayon Bockarie; Dennis Bente; Slobodan Paessler
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

7.  The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever.

Authors:  Yan Liu; Bin Wu; Slobodan Paessler; David H Walker; Robert B Tesh; Xue-jie Yu
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 8.  Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses.

Authors:  Bjoern Meyer; Hinh Ly
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

9.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

Review 10.  The search for animal models for Lassa fever vaccine development.

Authors:  Igor S Lukashevich
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.